Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Ozempic vs Mounjaro: Key Differences BODYWELLE Phentermine Hydrochloride (Keltman Pharmaceuticals Inc.): FDA Package Insert Does Ozempic Cause Hair Loss? Take Care by Hers Can Semaglutide Cause Acid Reflux? Symptoms and Management Fella Health